 |
|
|
RedPath’s
PathFinderTG®
represents over 17 years
of research and development and is clinically validated at an average 95% accuracy
rate across multiple organs, specimen types and diagnostic questions
for cancer. |
|
|
|
|
|
|
REDPATH INTEGRATED PATHOLOGY
RedPath Integrated Pathology is changing patient lives. RedPath is a CLIA/CAP accredited reference laboratory providing advanced molecular support for difficult oncology cases. RedPath's services are used when standard pathology methods produce "indeterminate, atypical, equivocal and non-diagnostic specimen" results.
RedPath’s patented PathFinderTG® test integrates the original pathology evaluation with the power of genomics to render a definitive diagnosis from existing specimens. The results provide useful and sometimes dramatic information for doctors to plan the best course of treatment for each patient's unique diagnosis.
|
|
|
|
|
| |
|
|
Learn how RedPath's
PathFinderTG provides early and definitive diagnosis |
|
Learn how early
and definitive diagnosis can help you |
| More |
|
More |
|
| |
|
|
|
|
|
 |
|
|
|
|
The Bonding of BioBuds
Read
What pathology examination of your Esophageal Biopsy can tell your doctor about the health of your esophagus.
Read
More News |
| |
|
 |
|
|
